News
News
November 2018
New study about Gold Anchor confirms low risk of infection and great marker stability
We are happy to share with you a new study about Gold Anchor from the Karolinska University Hospital in Stockholm, Sweden.
Conclusion of the study: The use of thin needles for the implantation of fiducials appears to reduce the rate of infection despite the use of a single dose of non-broad-spectrum antibiotics as prophylaxis. The marker construct appears to provide stability in the tissues.
Read more
September 2018
Strong Clinical Data for Sonablate HIFU
The UK urologist group led by University College and Imperial College London published 5-year outcomes from a multicenter study following focal therapy treatment with its Sonablate technology of 625 medium to high-risk clinically significant nonmetastatic prostate cancer patients.
Read more
We take our time with you
We look forward to getting in touch with you
Thank you for your inquiry. We will answer you as soon as possible.
This site uses cookies to improve your user experience. You may find out more about in our Privacy Policy. By using this website you accept our use of cookies.
OK